RSS Email Newsletters your site
Partnership with Atlantic Biotech Labs to Distribute UR Code™ Product
Florida and Tennessee
for both companies, beginning with the criminal justice markets in
Florida and Tennessee,” said Marker Test Chief Executive Officer Kim Christensen.
SCOTTDALE, AZ (PRWEB) JANUARY 29, 2017
SCOTTSDALE - January 28, 2017 – Marker Test Diagnostics, Inc., a leading international supplier to the
drug testing industry, has entered into an exclusive agreement with Atlantic Biotech Labs of Pompano
Beach FL, to distribute its UR Code™ urine marker product.
UR Code is a urine marker that “bar-codes” a subject’s urine and eliminates the need to supervise urine
collection. In the form of a soft gel capsule, UR Code is the only patented test worldwide that can analytically
detect sample substitution, dilution or adulteration, resulting in unparalleled accuracy and reliability. This
superior level of accuracy eliminates up to 30% of the tests that are deliberately falsified in urine drug testing.
This agreement provides Atlantic Biotech with a distinct competitive advantage by delivering improved
confirmation testing results to the criminal justice markets (corrections, probation, parole, and drug courts)
in the states of Florida and Tennessee. With drug use on the rise and an out of control opioid epidemic
nationally, the UR Code product and Atlantic Biotech labs can have a major impact in assisting the criminal
justice markets with the latest innovative tools to better manage the clients they serve.
“The partnership with Atlantic Biotech provides for a very unique opportunity for both companies, beginning
with the criminal justice markets in Florida and Tennessee,” said Marker Test Chief Executive Officer Kim
Christensen. “Together, we believe the specificity of the product will allow Atlantic Biotech Labs to expand
their technical operations and expertise in the corrections, probation, parole, and drug court markets by
providing the latest technology with enhanced and accurate results reporting to the market decision makers.”
Representatives from both companies are on-site at the AXIS (Addiction eXecutives Industry Summit) in
Naples, FL from January 28 to February 1 (booth 26) at the Naples Grand Beach Resort, and at DATIA
(Drug and Alcohol Industry Association) conference May 16 -18, in Orlando, FL.
About Marker Test Diagnostics
Founded in 2013, Marker Test Diagnostics is the producer of UR Code (TM), an innovative urine marker for
the drug testing market. Marker Test Diagnostics has completed research studies in the field of addiction and
sports, and has collaborated and published scientific papers with the Olympic Doping Laboratory at the
University of California Los Angeles, and the Columbia University / New York State Psychiatric Institute.
For more information about Marker Test Diagnostics, visit http://www.markertest.com.
About Atlantic Biotech, LLC
Founded in 2013, Atlantic Biotech, a national provider of drug confirmation testing services utilizes the latest
LC/MS/MS technology available today to provide accurate and timely (24 hour) qualitative and quantitative
toxicology results. As legal and compliance pressures continue to evolve in the face of today’s toxicology
industry, Atlantic Biotech is unsurpassed and leads the industry in compliance. Atlantic Biotech delivers
customizable panel solutions along with stringent control, and unparalleled customer service for a wide
range of toxicology markets. As a company, a key emphasis lies with being a partner in patient health by
working with physicians and facilities more like a family than a large corporation. Atlantic Biotech is taking a
leadership role to address the evolving and pressing concerns with “observed” urine collection by ensuring
that samples belong to the correct patient and no one else. Atlantic Biotech knows each and every time
“lives are on the line.”